arrow
M

Maram Albandak

al-quds university
H指数:7
被引数:192

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Tofacitinib vs Vedolizumab: A 36-Month Journey in Ulcerative Proctitis Management With Insights on Efficacy and Safety: Propensity-Matched Cohort Analysis Using TriNetX Database

托法替尼 vs. 韦多利珠单抗:溃疡性直肠炎管理中的36个月旅程——关于疗效和安全性的见解:基于TriNetX数据库的倾向性匹配队列分析

2025-10-010
PRE
Efficacy of Potassium Channel Acid Blockers for Non-Erosive Reflux Disease: A Systematic Review and Meta-Analysis

钾通道酸阻滞剂对非糜烂性反流病的疗效:一项系统评价和荟萃分析

2025-10-010
PRE
Efficacy and Safety of GLP-1 Receptor Agonists in Metabolic-Associated Steatohepatitis With Significant Fibrosis or Cirrhosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

GLP-1受体激动剂在伴有显著纤维化或肝硬化的代谢相关脂肪性肝炎中的有效性和安全性:一项随机对照试验的系统评价和荟萃分析

2025-10-010
PRE
COMPARATIVE EFFECTIVENESS OF ORAL JANUS KINASE INHIBITORS VERSUS VEDOLIZUMAB IN ULCERATIVE COLITIS AFTER ANTI-TNF THERAPY FAILURE: A SYSTEMATIC REVIEW AND META-ANALYSIS

抗肿瘤坏死因子治疗失败后,口服JAK抑制剂与 Vedolizumab 在溃疡性结肠炎中的比较有效性:一项系统评价和荟萃分析

2025-02-280
PRE